Provided by Tiger Fintech (Singapore) Pte. Ltd.

Harmony Biosciences Holdings, Inc.

33.19
+0.0000
Post-market: 33.190.00000.00%19:05 EDT
Volume:536.00K
Turnover:17.69M
Market Cap:1.90B
PE:13.22
High:33.42
Open:32.70
Low:32.19
Close:33.19
Loading ...

Harmony Biosciences to Participate in 24th Annual Needham Virtual Healthcare Conference

Business Wire
·
26 Mar

BRIEF-Harmony Biosciences Names Adam Zaeske As Chief Commercial Officer

Reuters
·
24 Mar

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

THOMSON REUTERS
·
24 Mar

Harmony Biosciences Names Adam Zaeske as Chief Commercial Officer to Lead the Next Phase of Commercial Growth as Its Portfolio Expands

Business Wire
·
24 Mar

HRMY Down 10.8% in Six Months: How Should You Play the Stock?

Zacks
·
20 Mar

Mizuho Adjusts PT on Harmony Biosciences Holdings to $44 From $42, Maintains Outperform Rating

MT Newswires Live
·
17 Mar

Harmony Biosciences to Participate in Upcoming Investor Conferences

Business Wire
·
04 Mar

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Simply Wall St.
·
28 Feb

UBS Adjusts Price Target on Harmony Biosciences to $55 From $56, Keeps Buy Rating

MT Newswires Live
·
27 Feb

Harmony Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
27 Feb

Harmony Biosciences price target lowered to $70 from $75 at H.C. Wainwright

TIPRANKS
·
27 Feb

Stock Track | Harmony Biosciences Plummets 5% on Pipeline and Generic Competition Concerns

Stock Track
·
26 Feb

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Zacks
·
26 Feb

Cautious Outlook: Sell Rating for Harmony Biosciences Due to Pipeline Concerns and Generic Competition Risks

TIPRANKS
·
26 Feb

Harmony Biosciences Holdings Inc (HRMY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com
·
26 Feb

Harmony Biosciences Files for Mixed Shelf - SEC Filing

THOMSON REUTERS
·
26 Feb